Ken Saida Tsuyoshi Fukuda Kana Mizuno Masao Ogura Koichi Kamei Shuichi Ito
10.3389/fped.2019.00519
Front Pediatr
2019 Dec 17;7:519.
c3 mutation atypical hemolytic uremic syndrome eculizumab pharmacodynamics pharmacokinetics
CC BY
https://pubmed.ncbi.nlm.nih.gov/31921730/
Case Reports
PMC6929516
31921730
Pharmacokinetics and Pharmacodynamics Estimation of Eculizumab in a 2-Year-Old Girl With Atypical Hemolytic Uremic Syndrome: A Case Report With 4-Year Follow-Up
2019